Track Record

Our focus on value creation is why healthcare leaders trust us.

October 2024
Acted as the sole financial advisor to the Ovizio team and shareholders in the sale of 100% of its shares to Chemometec, a Danish listed company
July 2024
Reverse Merger operation on Exactcure, a Digital Health company developing IA solutions
May 2024
Support of Genoscience team and shareholders in a 4m€ private placement with individuals
April 2024
Support of Curio in its 8m€ Series A with RYSE capital
Fev 2024
Support of Mega Dental owners in the acquisitions of products to internalize in a Corporate Development As A Service mandate
Jan 2024
Support of operational team and shareholders in the conclusion of a Strategic Partnership with an industrial to co-develop and market MGB products